With that in mind, let's consider two stocks that haven't performed well recently and are now near their 52-week lows but that are still worth investing in: CRISPR Therapeutics (NASDAQ: CRSP) and ...

Nvidia ( NVDA 3.40%) is one of the most widely followed stocks today, and it's easy to see why. Its lead in the artificial ...

With so many ski areas in New England, Bostonians don’t have to travel too far to hit the slopes. Here are some expert tips ...

Announced at CES 2025 and already available with a 10% discount (20% in the UK) from Anker's store, this high-capacity bank ...

Chris Stapleton, one of the biggest names in country and rock n' roll, has 16 shows lined up in the United States this summer ...

Cryptocurrencies in 2025 are expected to boom, and smart investors are looking for promising opportunities to capitalize on ...

With thousands of cryptocurrencies to choose from, it can be overwhelming to decide where to put your money. However, three ...

Buy 1 Year and Get 1 Year FREE on TheStreet Pro. Act now before it's gone ⏰ This is partly thanks to the changing shopping ...

Molson Coors Beverage's margin is at risk of further compression, with gross margin failing to expand. Click here to read why ...

The JPMorgan Nasdaq Equity Premium Income ETF holds 103 stocks that closely mirror the Nasdaq-100 index. It writes covered ...

We recently published a list of 10 Best Bank Stocks to Buy in 2025. In this article, we are going to take a look at where PNC ...

The SteelSeries Apex Pro Gen 3 TKL isn’t perfect, but it has a lot to offer in the ways that matter most to competitive ...